Also found in: Wikipedia.
LNCaPLymph Node Carcinoma of the Prostate
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
In the present in vitro study, PSES-pAdenoVator-PSA-NDRG2-IRES-GFP plasmid was used to overexpress NDRG2 in LNCaP cells.
According to the researchers, "Melatonin treatment dramatically reduced the number of prostate cancer cells and stopped cell cycle progression in both LNCaP and PC3 cells." That means that no matter whether the prostate cancer cells were sensitive to testosterone or not, they were all stopped with melatonin.
Sensitivity to irradiation of PC3 and LNCaP cells was reduced by HULC
As expression levels of AR-V7 are generally low (1.2 and 0.4 copies/cell in VCaP and LNCaP, respectively) (22), we amplified the signals by an array of AR-V7 padlocks.
injections of 1mg/kg in 41 days) mice xenografted with LNCaP cells [89].
Before feeding the LNCaP cells with CM, TNF-[alpha] (Invitrogen), IL-6, and IL-1[beta] (Boster Biological Technology Co., US) levels were assessed using an enzyme-linked immunosorbent assay in accordance with the manufacturer's recommendations.
FA has been reported to induce apoptosis in TT thyroid cancer cells and LNCaP prostate cancer cells.
analyzed PPAR[gamma] levels in the castration-sensitive LNCaP cells and two AR-negative, castration-resistant cell lines, DU145 and PC-3 cells.
africana showed growth inhibition of a human prostate cancer cell line (PC-3) and epithelial cells derived from a lymph-node carcinoma of the prostate (LNCaP) by 50% at 2.5 [micro]L/mL and also induced significant apoptosis in both cell lines (PC-3 and LNCaP) at 2.5 [micro]L/mL compared to untreated cells.